J
2023
Ketamine disrupts locomotion and electrolocation in a novel model of schizophrenia, Gnathonemus petersii fish
LANGOVA, Veronika, Petra HORKA, Jan HUBENY, Tomas NOVAK, Karel VALES et. al.
Základní údaje
Originální název
Ketamine disrupts locomotion and electrolocation in a novel model of schizophrenia, Gnathonemus petersii fish
Autoři
LANGOVA, Veronika, Petra HORKA, Jan HUBENY, Tomas NOVAK, Karel VALES, Petr ADAMEK, Katerina HOLUBOVA a Jiri HORACEK
Vydání
Journal of Neuroscience Research, HOBOKEN, WILEY, 2023, 0360-4012
Další údaje
Typ výsledku
Článek v odborném periodiku
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.200 v roce 2022
Kód RIV
RIV/00216224:90249/23:00133574
Organizační jednotka
CZECRIN IV
Klíčová slova česky
electrolocation; Gnathonemus petersii; positive symptoms; schizophrenia model; weakly electric fish
Klíčová slova anglicky
electrolocation; Gnathonemus petersii; positive symptoms; schizophrenia model; weakly electric fish
Příznaky
Mezinárodní význam, Recenzováno
V originále
The present study aimed to examine a weakly electric fish Gnathonemus petersii (G. petersii) as a candidate model organism of glutamatergic theory of schizophrenia. The idea of G. petersii elevating the modeling of schizophrenia symptoms is based on the fish's electrolocation and electrocommunication abilities. Fish were exposed to the NMDA antagonist ketamine in two distinct series differing in the dose of ketamine. The main finding revealed ketamine-induced disruption of the relationship between electric signaling and behavior indicating impairment of fish navigation. Moreover, lower doses of ketamine significantly increased locomotion and erratic movement and higher doses of ketamine reduced the number of electric organ discharges indicating successful induction of positive schizophrenia-like symptoms and disruption of fish navigation. Additionally, a low dose of haloperidol was used to test the normalization of the positive symptoms to suggest a predictive validity of the model. However, although successfully induced, positive symptoms were not normalized using the low dose of haloperidol; hence, more doses of the typical antipsychotic haloperidol and probably also of a representative of atypical antipsychotic drugs need to be examined to confirm the predictive validity of the model.
Návaznosti
90249, velká výzkumná infrastruktura | |
Zobrazeno: 9. 11. 2024 22:41